PTX3 and breast carcinoma: In addition, treating breast cancer with CDDP promoted the level of CEBPD in CAFs as well as tumor-associated macrophages (TAMs) and led to chemoresistance through pentraxin 3 (PTX3)-induced invasion, metastasis, and stemness (62).